Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1493526/000149315219002930/form10-q.htm
June 2019
February 2019
January 2019
December 2018
November 2018
June 2018
July 2017
July 2017
September 2016
September 2015
Document and Entity Information | 6 Months Ended |
---|---|
Jun. 30, 2018 shares | |
Document And Entity Information | |
Entity Registrant Name | PROTECT PHARMACEUTICAL Corp |
Entity Central Index Key | 0001493526 |
Document Type | 10-Q |
Document Period End Date | Jun. 30, 2018 |
Amendment Flag | false |
Current Fiscal Year End Date | --12-31 |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business flag | true |
Entity Emerging Growth Company | false |
Entity Ex Transition Period | false |
Entity Common Stock, Shares Outstanding | 1,111,460 |
Trading Symbol | PRTT |
Document Fiscal Period Focus | Q2 |
Document Fiscal Year Focus | 2018 |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1493526/000149315219002930/form10-q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Protect Pharmaceutical Corp.
Protect Pharmaceutical Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Protect Pharmaceutical Corp provided additional information to their SEC Filing as exhibits
Ticker: PRTT
CIK: 1493526
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-19-002930
Submitted to the SEC: Wed Mar 06 2019 3:54:08 PM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Saturday, June 30, 2018
Industry: Pharmaceutical Preparations